94 related articles for article (PubMed ID: 6489667)
1. [Effects of delayed-action metoprolol evaluated in hypertensive patients responsive to therapy subdivided in 2 different age groups].
Carpentiere G; Marino S; Castello F; Castello A; Cellura M
G Ital Cardiol; 1984 Jul; 14(7):530-3. PubMed ID: 6489667
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
Karachalios GN
Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of the slow release formulations of metoprolol and oxprenolol in hypertension.
Comerford MB; Besterman EM
Ann Clin Res; 1982 Feb; 14(1):27-31. PubMed ID: 7137874
[TBL] [Abstract][Full Text] [Related]
4. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
Hoffmann J
Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
[TBL] [Abstract][Full Text] [Related]
5. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
[TBL] [Abstract][Full Text] [Related]
7. Metoprolol in hypertension: an open evaluation.
Assaykeen TA; Michell G
Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
Dahlöf B; Hosie J
Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
[TBL] [Abstract][Full Text] [Related]
9. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
10. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
[TBL] [Abstract][Full Text] [Related]
11. The long-term antihypertensive efficacy and safety of a new felodipine-metoprolol combination tablet. The Swedish/UK and German Study Groups.
Hosie J; Dahlöf B; Klein G
Blood Press Suppl; 1993; 1():46-50. PubMed ID: 8173690
[TBL] [Abstract][Full Text] [Related]
12. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
Asplund J; Ohman P
Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
Lavenius B; Hansson L
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
[TBL] [Abstract][Full Text] [Related]
14. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
Frishman WH; Hainer JW; Sugg J;
Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
[TBL] [Abstract][Full Text] [Related]
15. [Non-invasive long-term monitoring of blood pressure and arrhythmias in hypertensive patients treated with metoprolol].
Palma Gamiz JL; Codina J
Wien Med Wochenschr; 1988 Jan; 138(1-2):38-40. PubMed ID: 2451359
[TBL] [Abstract][Full Text] [Related]
16. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
17. Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents.
Lyngstam O; Rydén L
Acta Med Scand; 1981; 209(4):261-6. PubMed ID: 7015797
[TBL] [Abstract][Full Text] [Related]
18. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
19. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antihypertensive effects of indapamide and metoprolol.
Kubik MM; Coote JH
Postgrad Med J; 1981; 57 Suppl 2():44-50. PubMed ID: 7033946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
